We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Chloroquine Prevents Tumor Formation in Mouse Models

By Biotechdaily staff writers
Posted on 15 Jan 2008
Cancer researchers have found that the anti-malarial drug chloroquine prevented development of tumors in two different mouse models. More...


Investigators from St. Jude Children's Research Hospital (Memphis, TN, USA) studied the effect of chloroquine, which is known to mildly suppress the immune system, on tumor formation in a mouse model of Burkitt lymphoma and in ATM-deficient mice (a mouse model of ataxia telangiectasia).

They reported in the December 20, 2007, online edition of the Journal of Clinical Investigation that chloroquine effectively prevented cancer in the two mouse models. The mouse model of Burkitt lymphoma is a Myc-induced lymphoma, with Myc being protooncogene that is overexpressed in a wide range of human cancers. The drug also impaired spontaneous lymphoma development in the mouse model of ataxia telangiectasia.

Anti-cancer activity in both models was dependent on the activity of the p53 gene.
Chloroquine appeared to be effective in inducing the cellular features of autophagy (self-eating) and mediating its effects by inducing lysosomal stress and provoking p53-dependent cell death. The drug failed to inhibit tumor formation that was p53-independent.

The authors suggested that chloroquine or similar agents targeting lysosome-mediated degradation might be effective in cancer prevention.


Related Links:
St. Jude Children's Research Hospital

New
Gold Member
Aspiration System
VACUSAFE
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Rapid Sepsis Test
SeptiCyte RAPID
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.